N-Hydroxythiosemicarbazones: Synthesis and in vitro antitubercular activity

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 7, 2007, Pages 1888-1891

  Sriram, Dharmarajan ^a   Yogeeswari, Perumal ^a   Dhakla, Prathiba ^a   Senthilkumar, Palaniappan ^a   Banerjee, Debjani ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Antimycobacterial activity; Thiosemicarbazones

Indexed keywords

(4 BROMOPHENYL)(PHENYL)METHANONE N HYDROXYTHIOSEMICARBAZONE; ALDEHYDE; BENZYLAMINE DERIVATIVE; ETHAMBUTOL; HYDROXYLAMINE; ISONIAZID; KETONE; RIFAMPICIN; THIOSEMICARBAZONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REACTION ANALYSIS; TECHNIQUE; VERO CELL;

AGAR; ANIMALS; ANTITUBERCULAR AGENTS; CERCOPITHECUS AETHIOPS; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; MODELS, CHEMICAL; MOLECULAR CONFORMATION; MYCOBACTERIUM TUBERCULOSIS; SEMICARBAZIDES; SEMICARBAZONES; TEMPERATURE; VERO CELLS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33847664299     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.01.037     Document Type: Article

References (13)

1. Ginsburg A.S., Grosset J.H., and Bishai W.R. Lancet Infect. Dis. 3 (2003) 432
2. Raviglione M.C., Snider D.E., and Kochi A. JAMA 273 (1995) 220
3. World Health Organization. The World Health Organization Global Tuberculosis Program, 2003. Further info at the web site: http://www.who.int/gtb/.
4. Espinal M.A. Tuberculosis 83 (2003) 44
5. Global Alliance for Tuberculosis Drug Development. Scientific blueprint for tuberculosis drug development. Tuberculosis 2001, 81 (Suppl. 1), 1-52.
6. O'Brien R.J., and Nunn P.P. Am. J. Respir. Crit. Care Med. 1635 (2001) 1055
7. Sahbazian B., and Weis S.E. Clin. Chest Med. 26 (2005) 273
8. Sriram D., Yogeeswari P., Thirumurugan R., and Kumar P.R. J. Med. Chem. 49 (2006) 3448
9. Khazi I.M., Koti R.S., Chadha M.V., Mahajanshetti C.S., and Gadad A.K. Arzneimittelforschung 55 (2005) 107
10. Milczarska B., Foks H., Trapkowski Z., Milzynska-Kolaczek A., Janowiec M., Zwolska Z., and Andrzejczyk Z. Acta Pol. Pharm. 55 (1998) 289
11. 3OS: C, 48.01; H, 3.45; N, 12.00. Found: C, 47.91; H, 3.49; N, 11.99.
12. National Committee for Clinical Laboratory Standards. Antimycobacterial susceptibility testing. Proposed standard M24-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1990.
13. Gundersen L.L., Nissen-Meyer J., and Spilsberg B. J. Med. Chem. 45 (2002) 1383